Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics - Archive ouverte HAL
Article Dans Une Revue Exploration of Targeted Anti-tumor Therapy Année : 2022

Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics

Résumé

During the past two decades, tremendous progress has been made in the dendrimer-based delivery of therapeutic molecules including, for instance, small molecules, macromolecules, and genes. This review deals with recent successes in the development of promising biocompatible phosphorus dendrimers, a specific type of dendrimer, to deliver genes to treat cancers.
Fichier principal
Vignette du fichier
Mignani, Engineered phosphorus dendrimers, 2022.pdf (1.88 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03659099 , version 1 (04-05-2022)

Licence

Identifiants

Citer

Serge Mignani, Xiangyang Shi, Maria Bryszewska, Dzmitry Shcharbin, Jean-Pierre Majoral. Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics. Exploration of Targeted Anti-tumor Therapy, 2022, 3 (1), pp.50-61. ⟨10.37349/etat.2022.00071⟩. ⟨hal-03659099⟩
53 Consultations
80 Téléchargements

Altmetric

Partager

More